Cargando…

A Diagnostic Model for Screening Diabetic Retinopathy Using the Hand-Held Electroretinogram Device RETeval

PURPOSE: To construct a proper model to screen for diabetic retinopathy (DR) with the RETeval. METHOD: This was a cross-sectional study. Two hundred thirty-two diabetic patients and seventy controls were recruited. The DR risk assessment protocol was performed to obtain subjects’ DR risk score using...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Xiaowen, Li, Zijing, Zeng, Peng, Wang, Jing, Liang, Jiaqi, Lan, Yuqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074966/
https://www.ncbi.nlm.nih.gov/pubmed/33912134
http://dx.doi.org/10.3389/fendo.2021.632457
_version_ 1783684458560356352
author Deng, Xiaowen
Li, Zijing
Zeng, Peng
Wang, Jing
Liang, Jiaqi
Lan, Yuqing
author_facet Deng, Xiaowen
Li, Zijing
Zeng, Peng
Wang, Jing
Liang, Jiaqi
Lan, Yuqing
author_sort Deng, Xiaowen
collection PubMed
description PURPOSE: To construct a proper model to screen for diabetic retinopathy (DR) with the RETeval. METHOD: This was a cross-sectional study. Two hundred thirty-two diabetic patients and seventy controls were recruited. The DR risk assessment protocol was performed to obtain subjects’ DR risk score using the RETeval. Afterwards, the receiver operating characteristic (ROC) curve was used to determine the best cutoff for diagnosing DR. Random forest and decision tree models were constructed. RESULTS: With increasing DR severity, the DR score gradually increased. When the DR score was used to diagnose DR, the ROC curve had an area under the curve of 0.881 (95% confidence interval: 0.836-0.927, P < 0.001), with a best cutoff value of 22.95, a sensitivity of 74.3% (95 CI: 66.0%~82.6%), and a specificity of 90.6% (95 CI: 83.7% ~94.8%). The top four risk factors selected by the random forest were used to construct the decision tree for diagnosing DR, which had a sensitivity of 93.3% (95% CI: 86.3%~97.0%) and a specificity of 80.3% (95% CI: 72.1% ~86.6%). CONCLUSIONS: The DR risk assessment protocol combined with the decision tree model was innovatively used to evaluate the risk of DR, improving the sensitivity of diagnosis, which makes this method more suitable than the current protocol for DR screening.
format Online
Article
Text
id pubmed-8074966
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-80749662021-04-27 A Diagnostic Model for Screening Diabetic Retinopathy Using the Hand-Held Electroretinogram Device RETeval Deng, Xiaowen Li, Zijing Zeng, Peng Wang, Jing Liang, Jiaqi Lan, Yuqing Front Endocrinol (Lausanne) Endocrinology PURPOSE: To construct a proper model to screen for diabetic retinopathy (DR) with the RETeval. METHOD: This was a cross-sectional study. Two hundred thirty-two diabetic patients and seventy controls were recruited. The DR risk assessment protocol was performed to obtain subjects’ DR risk score using the RETeval. Afterwards, the receiver operating characteristic (ROC) curve was used to determine the best cutoff for diagnosing DR. Random forest and decision tree models were constructed. RESULTS: With increasing DR severity, the DR score gradually increased. When the DR score was used to diagnose DR, the ROC curve had an area under the curve of 0.881 (95% confidence interval: 0.836-0.927, P < 0.001), with a best cutoff value of 22.95, a sensitivity of 74.3% (95 CI: 66.0%~82.6%), and a specificity of 90.6% (95 CI: 83.7% ~94.8%). The top four risk factors selected by the random forest were used to construct the decision tree for diagnosing DR, which had a sensitivity of 93.3% (95% CI: 86.3%~97.0%) and a specificity of 80.3% (95% CI: 72.1% ~86.6%). CONCLUSIONS: The DR risk assessment protocol combined with the decision tree model was innovatively used to evaluate the risk of DR, improving the sensitivity of diagnosis, which makes this method more suitable than the current protocol for DR screening. Frontiers Media S.A. 2021-04-12 /pmc/articles/PMC8074966/ /pubmed/33912134 http://dx.doi.org/10.3389/fendo.2021.632457 Text en Copyright © 2021 Deng, Li, Zeng, Wang, Liang and Lan https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Deng, Xiaowen
Li, Zijing
Zeng, Peng
Wang, Jing
Liang, Jiaqi
Lan, Yuqing
A Diagnostic Model for Screening Diabetic Retinopathy Using the Hand-Held Electroretinogram Device RETeval
title A Diagnostic Model for Screening Diabetic Retinopathy Using the Hand-Held Electroretinogram Device RETeval
title_full A Diagnostic Model for Screening Diabetic Retinopathy Using the Hand-Held Electroretinogram Device RETeval
title_fullStr A Diagnostic Model for Screening Diabetic Retinopathy Using the Hand-Held Electroretinogram Device RETeval
title_full_unstemmed A Diagnostic Model for Screening Diabetic Retinopathy Using the Hand-Held Electroretinogram Device RETeval
title_short A Diagnostic Model for Screening Diabetic Retinopathy Using the Hand-Held Electroretinogram Device RETeval
title_sort diagnostic model for screening diabetic retinopathy using the hand-held electroretinogram device reteval
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074966/
https://www.ncbi.nlm.nih.gov/pubmed/33912134
http://dx.doi.org/10.3389/fendo.2021.632457
work_keys_str_mv AT dengxiaowen adiagnosticmodelforscreeningdiabeticretinopathyusingthehandheldelectroretinogramdevicereteval
AT lizijing adiagnosticmodelforscreeningdiabeticretinopathyusingthehandheldelectroretinogramdevicereteval
AT zengpeng adiagnosticmodelforscreeningdiabeticretinopathyusingthehandheldelectroretinogramdevicereteval
AT wangjing adiagnosticmodelforscreeningdiabeticretinopathyusingthehandheldelectroretinogramdevicereteval
AT liangjiaqi adiagnosticmodelforscreeningdiabeticretinopathyusingthehandheldelectroretinogramdevicereteval
AT lanyuqing adiagnosticmodelforscreeningdiabeticretinopathyusingthehandheldelectroretinogramdevicereteval
AT dengxiaowen diagnosticmodelforscreeningdiabeticretinopathyusingthehandheldelectroretinogramdevicereteval
AT lizijing diagnosticmodelforscreeningdiabeticretinopathyusingthehandheldelectroretinogramdevicereteval
AT zengpeng diagnosticmodelforscreeningdiabeticretinopathyusingthehandheldelectroretinogramdevicereteval
AT wangjing diagnosticmodelforscreeningdiabeticretinopathyusingthehandheldelectroretinogramdevicereteval
AT liangjiaqi diagnosticmodelforscreeningdiabeticretinopathyusingthehandheldelectroretinogramdevicereteval
AT lanyuqing diagnosticmodelforscreeningdiabeticretinopathyusingthehandheldelectroretinogramdevicereteval